2924824-48-4

AChE/BChE-IN-10 Chemical Structure
2924824-48-4

Chemical Structure

AChE/BChE-IN-10

  • CAS No.: 2924824-48-4
  • Formula:C26H30N2O2
  • Molecular Weight:402.53

IUPAC Name: 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-4-(methyl(6-(N-methyl-5-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexyl)carbamoyl)benzoic acid compound with 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-(methyl(6-(N-methyl-5-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexyl)carbamoyl)benzoic acid (1:1)

InChIKey: AIIWJMPOAUNFLG-UHFFFAOYSA-N

SMILES: O=C(NCCC1CCN(CC2=CC=CC=C2)CC1)C3=CC=C4C=C(OC)C=CC4=C3

Biological Activity: AChE/BChE-IN-10 (Compound 7b) is a potent dual AChE and BChE inhibitor with IC50 values of 0.176, and 0.47 μM, respectively. AChE/BChE-IN-10 shows good blood brain barrier permeability. AChE/BChE-IN-10 can inhibit Aβ-aggregation and be used in Alzheimer’s disease (AD) research[1].

Cat. No. Product Name Purity Description Pricing
HY-151368
AChE/BChE-IN-10 99.67% AChE/BChE-IN-10 (Compound 7b) is a potent dual AChE and BChE inhibitor with IC50 values of 0.176, and 0.47 μM, respectively. AChE/BChE-IN-10 shows good blood brain barrier permeability. AChE/BChE-IN-10 can inhibit Aβ-aggregation and be used in Alzheimer’s disease (AD) research.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References